Eplerenone is an aldosterone antagonist used as an adjunct in the
management of chronic heart failure.
Eplerenone is specifically indicated for the
reduction of risk of cardiovascular death in patients with heart
failure and left ventricular dysfunction within 3–14 days of an acute
myocardial infarction, in combination with standard therapies and as
treatment against hypertension.
No comments:
Post a Comment